Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Journal of the American College of Radiology : JACR
|
February 5, 2013
ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance
Steven C Eberhardt, Scott Carter, David D Casalino, et al.
Journal of the American College of Radiology : JACR
|
April 4, 2012
ACR Appropriateness Criteria® external-beam radiation therapy treatment planning for clinically localized prostate cancer
May Abdel-Wahab, Omar Mahmoud, Gregory Merrick, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 23, 2020
A biochemical definition of cure after brachytherapy for prostate cancer
Juanita M Crook, Chad Tang, Howard Thames, et al.
Brachytherapy
|
April 19, 2011
American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer
, Steven J Frank, V Elayne Arterbery, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 8, 2023
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study
Chad Tang, Jeremiah Sanders, Howard Thames, et al.
Brachytherapy
|
June 2, 2014
Response to Drs Rogers, Hayes, and Demanes
I-Chow Joe Hsu, Yoshiya Yamada, Dean G Assimos, et al.
Brachytherapy
|
December 26, 2013
ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer
I-Chow Joe Hsu, Yoshiya Yamada, Dean G Assimos, et al.
American Journal of Clinical Oncology
|
September 3, 2014
ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer
Paul L Nguyen, Ayal Aizer, Dean G Assimos, et al.
BJU International
|
January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
Peter Grimm, Ignace Billiet, David Bostwick, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Journal of the American College of Radiology : JACR
|
February 5, 2013
ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance
Steven C Eberhardt, Scott Carter, David D Casalino, et al.
Journal of the American College of Radiology : JACR
|
April 4, 2012
ACR Appropriateness Criteria® external-beam radiation therapy treatment planning for clinically localized prostate cancer
May Abdel-Wahab, Omar Mahmoud, Gregory Merrick, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 23, 2020
A biochemical definition of cure after brachytherapy for prostate cancer
Juanita M Crook, Chad Tang, Howard Thames, et al.
Brachytherapy
|
April 19, 2011
American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer
, Steven J Frank, V Elayne Arterbery, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 8, 2023
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study
Chad Tang, Jeremiah Sanders, Howard Thames, et al.
Brachytherapy
|
June 2, 2014
Response to Drs Rogers, Hayes, and Demanes
I-Chow Joe Hsu, Yoshiya Yamada, Dean G Assimos, et al.
Brachytherapy
|
December 26, 2013
ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer
I-Chow Joe Hsu, Yoshiya Yamada, Dean G Assimos, et al.
American Journal of Clinical Oncology
|
September 3, 2014
ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer
Paul L Nguyen, Ayal Aizer, Dean G Assimos, et al.
BJU International
|
January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
Peter Grimm, Ignace Billiet, David Bostwick, et al.
Page
of 5